The critical contribution of the Notch signaling pathway to vascular morphogenesis has been underscored by loss-of-function studies in mouse and zebraWsh. Nonetheless, a comprehensive understanding as to how this signaling system inXuences the formation of blood vessels at the cellular and molecular level is far from reached. Here, we provide a detailed analysis of the distribution of active Notch1 in relation to its DSL (Delta, Serrate, Lag2) ligands, Jagged1, Delta-like1, and Delta-like4, during progressive stages of vascular morphogenesis and maturation. Important diVerences in the cellular distribution of Notch ligands were found. Jagged1 (Jag1) was detected in "stalk cells" of the leading vasculature and at arterial branch points, a site where Delta-like4 (Dll4) was clearly absent. Dll4 was the only ligand expressed in "tip cells" at the end of the growing vascular sprouts. It was also present in stalk cells, capillaries, arterial endothelium, and in mural cells of mature arteries in a homogenous manner. Delta-like1 (Dll1) was observed in both arteries and veins of the developing network, but was also excluded from mature arterial branch points. These Wndings support alternative and distinct roles for Notch ligands during the angiogenic process.
Results and discussion
The Notch signaling pathway is widely known for its role in a myriad of processes during development. Nonetheless, the essential contribution of the Notch pathway to vascular morphogenesis has been revealed only recently. Deletion of many genes involved in Notch signal transduction, including: receptors, ligands, transcription factors, downstream targets, and molecules that participate in Notch processing, has resulted in severe vascular defects and embryonic lethality in mice (for reviews see Alva and Iruela-Arispe, 2004; Karsan, 2005; Shawber and Kitajewski, 2004) . Of the Notch receptors, the loss of Notch1 proved to be the most deleterious to vascular development (Conlon et al., 1995; Krebs et al., 2000; Swiatek et al., 1994) . Furthermore, several studies have demonstrated expression of Notch receptors and ligands in blood vessels and mural cells (Alva and Iruela-Arispe, 2004; Benedito and Duarte, 2005; Claxton and Fruttiger, 2004; Duarte et al., 2004; Gale et al., 2004; Shutter et al., 2000; Villa et al., 2001) . These studies have also generally agreed that in addition to capillaries, Notch ligands and receptors are mostly conWned to arteries, a Wnding that was subsequently supported by the requirement of Notch in establishing arterial identity through expression of EphrinB2 (Lawson et al., 2001) . However, despite these Wndings, a comprehensive analysis of the relationship between Notch signaling molecules throughout the stages of angiogenesis is lacking. Notch2 and Notch3 have been implicated in vascular regression and arterial homeostasis respectively, but do not appear to participate in vascular morphogenesis (Joutel et al., 1996; McCright et al., 2001) . In terms of the ligands, only the loss of either Jagged1 (Jag1) or Delta-like4 (Dll4) results in vascular defects, indicating that the other three Notch DSL ligands may not be as involved in vessel development.
Notably, analysis of the phenotypes exhibited by Jag1 (Xue et al., 1999) and Dll4 (Duarte et al., 2004; Gale et al., 2004; Krebs et al., 2004) knockout mice, suggested that these two ligands are not functionally redundant. Indeed, the onset of lethality would indicate that each one of these molecules might provide a diVerent array of signals through activation of Notch receptors. Expression studies can oVer critical information that could subsequently be used as a platform for mechanistic exploration. In the present study, our goal was to map the expression patterns of Notch1 and its ligands during the morphogenesis and maturation of the vasculature to gain insight as to which ligands contribute to speciWc events during vascular morphogenesis.
The embryonic vasculature expands in a three-dimensional manner and the distinction between immature and mature vessels is often diYcult. Therefore, a two-dimensional model of angiogenesis, such as that of the retina, provides an ideal system for studying gene expression patterns (for review see Dorrell and Friedlander, 2006) . In addition, the retinal vasculature displays all of the morphological hallmarks of angiogenesis, (sprouting, branching, fusion, remodeling, and maturation), making it an excellent platform in which to examine the expression of signaling molecules in relation to each stage of the angiogenic process (Fruttiger, 2002) .
The vessels of the mouse retina develop post-natally during the Wrst three weeks of life, with much of the maturation and remodeling occuring during the Wrst two weeks. The pri-mary vascular plexus migrates from the central retinal artery and expands in a planar manner with radially alternating veins and arteries extending from the optic nerve head. This allows for the simultaneous observation of diVerent stages of angiogenic expansion, as well as progressive maturation of arteries and veins ( Fig. 1A and B ) (Claxton and Fruttiger, 2004; Fruttiger, 2002; Fruttiger et al., 2000; Stone and Dreher, 1987) . We selected the time points of post-natal day (P) 3, 5, 7, and 15 for analysis based on the signiWcant morphological events occurring at those times. Using a repertoire of antibodies to Notch receptor and ligand domains, including active Notch1, Jag1, Delta-like1 (Dll1), and Dll4, we systematically examined their temporal and spatial distribution. PECAM-1 (also known as CD31) was used as a marker for vessel identiWcation. Since the mere presence of Notch1 is not equivalent to activity, we used an antibody that recognizes the cytosolic domain of Notch1 only after it has been cleaved by -secretase, the last step in the activation of this receptor (Weinmaster, 2000) .
Active Notch1 signaling in endothelial cells during vascular morphogenesis
Early in vessel initiation, at P3, active Notch1 was seen in the outer half of the vascular plexus, in immature capillaries and in tip and stalk cells ( Fig. 2A-C) . By P5 and 7, active Notch1 signaling appeared more sporadic and . Initiation of the primary vascular network begins at P0 when vessels sprout from the optic nerve head, and begin extending and fusing to form a capillary plexus (Dorrell et al., 2002) . The more mature vessels near the optic nerve head begin to remodel after P3 and develop into an alternating radial pattern of arteries and veins, connected by capillary beds. As the edge of the plexus reaches the perimeter of the retina (P7 and 8), vascular sprouts grow downward and form a secondary vascular plexus. By P15, the primary and secondary networks have matured and an intermediate plexus develops between the two established vascular layers (Dorrell et al., 2002) . (B) Progression and maturation of the vascular plexus. Non-proliferating "tip cells" containing long Wlopodia guide the vascular sprout, consisting of dividing "stalk cells" (Gerhardt et al., 2003) , as the immature network extends and forms by branching and fusion. Older vessels behind the leading edge remodel into arteries (which lack proximity of capillaries), veins, and capillary beds. Arteries, arterioles, veins, venuoles, and capillary beds are present in the mature vasculature. A, artery; V, vein. remained in the arterioles and capillaries at the peripheral two-thirds of the retina (Fig. 2D -I). At these immature stages, we also noted the presence of active Notch1 in vessels that appear to be destined for a venous fate ( Fig. 2H,  arrowhead) . It is possible to distinguish arteries from veins by P5, as the more mature vessels near the optic nerve head have begun to remodel and capillary clearance is observed in the vicinity of the arteries (Fig. 1B) . This arterial-venous distinction is more obvious by P7, as the radially alternating major arteries and veins from the center of the retina are thicker in girth than other vessels. The identiWcation of vessels based on these characteristics was conWrmed by EphB4 antibody staining (data not shown), a marker for venous endothelial cells (Gerety et al., 1999) . By P15, Notch1 activity was found in mature arteries and arterioles, although infrequent activity in venous endothelial cells was also detected at this time ( Fig. 2J, arrowheads) . Despite some activity in major vessels, the distribution of Notch1 during this late time point was mainly in the lower vascular plexus, particularly at branch points ( Fig. 2J -L).
Jagged1 expression in developing retinal vasculature
In comparison to Notch1, Jag1 expression was reduced at P3, but when present, was also scattered along the periphery of the retinal vessels. Cells expressing Jag1 were observed near branching points, as well as in the stalks at the leading edge of the vasculature, but we did not detect Jag1 in tip cells ( Fig. 3B and C) . As the vascular network begins to mature and remodel, the pattern of Jag1 staining expanded to cover the outer two-thirds of the growing plexus, major arteries and smaller arterioles, as well as neighboring non-endothelial cells by P5 and 7 ( Fig. 3D-I) . Many of the Jag1 positive cells appeared to be along the (B and C, arrows) . Notch1 is sporadically found in mature vessels at P5 and 7 (E and H, arrowheads) and in capillaries (E-I, arrows), particularly at branching points. By P15, active Notch1 is further diminished in the mature vessels, although it is still found in arteries, arterioles, and some veins (J, arrowheads), branch points of capillaries (K), and the lower plexus (J and L arrows). ON, optic nerve; A, artery; V, vein. Scale bars: 200 m (A, D, G, and J) and 50 m for the rest. edge of vessels and were likely pericytes or smooth muscle cells. The Jag1 positive cells outside the vascular template were probably of a neuronal nature ( Fig. 3H and I) , as Jag1 is also expressed in the central nervous system (Wang et al., 1998) . Importantly, at P15, we found a concentration of Jag1 positive cells in branch points of arteries ( Fig. 3J arrows, K circles and Fig. 6A and C). At these sites, cells expressing Jag1 appeared to be both endothelial and mural. This observation was particularly worth noting, considering Jag1 null mice die by embryonic day 11.5 as a result of a lack of vascular remodeling (Xue et al., 1999) . We quanti-Wed the distribution of Jag1 at these arterial branch points at P15. From three independent samples we determined the percentage of Jag1 positive cells at branches to be 67, 51, and 60% (average of 58%). In addition, increased Jag1 expression was also seen in mature arteries and arterioles, as well as in the lower vascular plexus during this time point (Fig. 3L ).
Delta-like1 expression patterns during vascular morphogenesis
Expression of Dll1 at P3 was high at the leading edge of the developing vasculature (outer third of the retinal plexus), but it was also observed along vessels that appear to be arterial ( Fig. 4A-C) . As the vessels remodeled and matured at P5 and 7, Dll1 remained in the capillaries, although expression was weak. At the leading edge, Dll1 was found in stalk cells, but it was absent in tip cells (Fig. 4C ). During this developmental time point, expression in arteries was also noted ( Fig. 4D-I) . Additionally, Dll1 was observed in veins at levels higher than that of arteries and capillaries ( Fig. 4E and H) . Fig. 3 . Distribution of Jagged1 in developing vessels, surrounding cells, and arterial branch points. Confocal images of mouse retinas stained with antibodies for endothelial marker PECAM-1 (red) and Jagged1 (green). (A-C) P3 expression of Jag1 is sparse, although some staining is seen in the immature plexus (B) and stalk cells (C) near points of vessel branching. Nuclei, veriWed by staining with nuclear dye TO-PRO-3 (data not shown), are marked by asterisks. Jag1 expression is visible in arteries (D, arrowhead) and is still found in stalk cells (F, arrows) at P5. Concurrently, Jag1 expression increases in the remodeling plexus (D and E, arrows) and in surrounding cells outside the vasculature (E and F, arrowheads). By P7, many Jag1 positive cells are seen adjacent to the vessels (H, arrow and I), although Jag1 can still be found inside capillaries (G, arrow) and mature vessels (H, arrowhead) . At P15, cells expressing Jag1 are observed wrapping around arterial branch points (J and K, circles) . Jag1 is also found in arteries and arterioles (K L, arrowheads), and non-vascular cells (K and L, arrows). ON, optic nerve; A, artery; V, vein. Although Dll1 has not been fully evaluated in the vasculature, its pattern constitutes an exception, as up to this point Notch receptors and ligands have only been detected in arterial and capillary vessels (Benedito and Duarte, 2005; Shutter et al., 2000; Villa et al., 2001) (Fig. 4E and H) . At P15, Dll1 was found throughout the retinal vasculature, in arteries, arterioles, capillaries, venuoles, and veins. Expression was not present in the vicinity of branching points of either arteries or veins. In addition, Dll1 was also found in cells outside of the vasculature, similar to the pattern of Jag1-stained retinas (Fig. 4J-L) .
Expression of Delta-like4 during vascular development
Much like the other DSL ligands, the expression pattern of Dll4 was also conWned to the edges of the growing plexus and in early stalk and tip cells at P3 ( Fig. 5A-C) . However, by P5 and 7, Dll4 was found in arteries and it was completely excluded from veins ( Fig. 5D and G) . Protein distribution of Dll4 displayed a banded pattern reminiscent of the previously reported transverse striping of Dll4 mRNA expression ( Fig. 5E and H) (Claxton and Fruttiger, 2004) . Dll4 also remained in the capillary plexus and smaller vessels, all of which was consistent with earlier in situ hybridization studies (Claxton and Fruttiger, 2004) . By P7, Dll4 staining was conspicuously absent from arterial branching points (Fig. 5H) . The arterial staining of Dll4 appeared to be increased by P15, in comparison to earlier stages and despite the reported decrease in Dll4 mRNA at this point ( Fig. 5J-K) (Claxton and Fruttiger, 2004) . A lack of Dll4 was also noted at branch points of mature arteries, based on the lack of co-localization of PECAM1 (Fig. 5K,   Fig. 4 . Expression of Delta-like1 during vascular morphogenesis. Co-immunolocalization of PECAM-1 (red) and Dll1 (green) antibodies in post-natal mouse retinas. (A-C) Dll1 is expressed in the periphery of P3 retinas (A, bracket), in capillaries (B, arrows), stalk cells (C, arrows), and in cells not associated with the vasculature (B and C, arrowheads). Remodeling vessels of both arterial and venous nature have increased Dll1 expression at P5 (D and E, arrowheads). Staining patterns also show Dll1 in the capillaries (E, arrow) and stalk cells (F, arrows). By P7, arteries and veins are more distinct, Dll1 expression is clearly seen in both types of vessels and appears increased in veins when compared to arteries (G and H, arrowheads) . Distribution of Dll1 in capillary and stalk cells is also increased and encompasses the entire vascular network (G-I, arrows). (J-L) This coverage is also visible at P15, as Dll1 is found in arteries, arterioles, capillaries, veins, venuoles, and the lower vascular plexus, but not at arterial branch points (K, circles). Non-vascular cells are also positive (K and L). ON, optic nerve; A, artery; V, vein. circles). This Notch ligand was also detected throughout the capillary plexus, the lower vascular layer, and at the termini of veins by this time (Fig. 5K and L) .
Distinct Jagged1 and Delta-like4 expression patterns in the mature vasculature
As the vasculature matures, we observed expression of Jag1 and Dll4 in mural cells directly associated with the vessels (Fig. 6A and B, arrows) , as well as in the endothelial cells of the mature arteries ( Fig. 6A and B, arrowheads) . Jag1 was located at arterial branch points during vessel maturation, while Dll4 was excluded from this site ( Fig. 6C and D) . In addition, Jag1 expression was detected in stalk cells, immediately behind the Dll4 positive tip cells, during the expansion of the vascular plexus. This pattern indicates alternative modes for activation of Notch signaling in these two non-overlapping cellular compartments ( Fig. 6E and F) .
Jagged1 and Delta-like4 expression in vascular smooth muscle cells
The Wnding of Jag1 and Dll4 positive cells that did not co-localize with PECAM1, led us to consider whether these cells were vascular smooth muscle cells (VSMC). Several cells expressing SMA were also positive for Jag1 staining at both P7 and P15 (Fig. 7A, arrows) , and in particular, SMA staining at arterial branch points at P15 also colocalized with Jag1 (Fig. 7A, arrowheads) . The merged images indicated that co-localization of Jag1 and SMA antibodies was highest along the edge of the cell that interacts with the vessel. In contrast to Jag1, Dll4 did not appear to be expressed in VSMC at P7 (Fig. 7B, P7 merged) , nor at Fig. 5 . Localization of Delta-like4 in tip cells, capillaries, and arterial vessels throughout retinal vascular development. Examination of the post-natal mouse retinal vasculature using Xuorescence immunohistochemistry for PECAM-1 (red) and Dll4 (green). (A and B) Expression of Dll4 is scattered in the vascular plexus of P3 retinas. At the leading vascular sprouts, Dll4 was seen in stalk and tip cells (C). Dll4 is also found in early maturing arteries by P5 (D, arrowheads), as well as in capillaries, arterioles (E, arrowheads), tip cells and stalk cells (D and F, arrows). However, arterial branch points lack Dll4 expression at P5, 7 and 15 (E, H, K, circles), despite increased arterial staining (G, H, J and K, arrowheads) . Dll4 is still seen in capillaries, stalk cells, and tip cells at P7 (H and I, arrows), but as the primary plexus reaches the edge of the retina and the lower vascular layers begin to form, Dll4 expression can be found near the termini of veins (L). ON, optic nerve; A, artery; V, vein. Scale bars: 200 m (A, D, G, and J), and 50 m (B, C, E, F, H, I, K, and L). arterial branch points at P15 (Fig. 7B, asterisk) where SMA was expressed (Fig. 7B, arrowhead) . However, some overlapping SMA and Dll4 expression was seen at P15 in mature arteries (Figs. 7B, P15 merged) . Further conWrmation of co-localization staining was achieved by evaluation of the specimens on a multiphoton Zeiss microscope equipped with a Meta Detector. The analysis integrates pixel location and excitation individually to avoid any bleed-through concerns (Supplemental Figure) .
Precedence for diVerences in Notch1 signaling induced by speciWc ligands has been reported recently. For example, lateral inhibition and prosensory functions of Notch signaling in the mouse inner ear are distinctly mediated by Jag1 and Dll1, respectively (Brooker et al., 2006) . Also, during T lymphocyte development, the activation and proliferation of T helper cells is diVerentially regulated by Dll1, Dll4, and Jag1 (Rutz et al., 2005) . The exclusivity of the expression patterns observed for these ligands could explain the diVerences in embryonic lethality and in phenotypes observed in the Jag1 and Dll4 null mice. Jag1 knockout mice have remodeling defects in the vasculature of the embryo and the yolk sac, resulting in hemorrhage and death by E11.5, indicating the contribution of this ligand at later stages of angiogenesis Fig. 6 . DiVerential expression of Jagged1 and Delta-like4 in arterial branches and tip cells. Comparison of immunostaining for PECAM-1 (red), Jag1 (A, C, and E, green), and Dll4 (B, D, and F, green) . Jag1 and Dll4 are both expressed in mature arteries (A and B, arrowheads) and in cells immediately adjacent to arteries in P15 mouse retinas (A and B, arrows) , while expression of Jag1 is also seen in non-vascular associated cells (A). When the expression of Jag1 and Dll4 are viewed separately, the localization of Jag1 around arterial branch points (C, arrows) and the exclusion of Dll4 from these branches (D, arrows) are more clearly deWned. Similarly in the leading edge of the early primary plexus, the patterns of expression of Jag1 and Dll4 appear to be associated with separate cell types, with Jag1 excluded from tip cells (E, boxed area) and Dll4 highly expressed in tip cells (F, boxed area). Scale bar: 50 m. (Xue et al., 1999) . Three separate studies of Dll4 deletion exhibited severe cardiovascular abnormalities including aortic stenosis, defective branching, arteriovenous connections, and pericardial edema (Duarte et al., 2004; Gale et al., 2004; Krebs et al., 2004) . These mutant mice exhibit an array of defects far more extensive than those displayed by Jag1 and result in lethality between E9.5-10.5 with varying degrees of haploinsuYciency depending on the genetic background.
Although Jag1 and Dll4 appear to be the major ligands involved in vascular development, further investigation of Dll1 is warranted. It has been previously reported that Dll1 is expressed in the endothelium of vessels during develop-ment (Beckers et al., 1999 ), yet its function has not been clearly delineated. Based on the expression pattern of Dll1 in both arteries and veins reported here, as well as the death of Dll1 knockout mice with hemorrhaging at E12 (Hrabe de Angelis et al., 1997) , it would appear that Dll1 is also an important contributor to Notch activation in blood vessels. The presence of Dll1 in veins might also explain the sporadic distribution of active Notch in venular endothelium. Together, these results provide new information regarding the temporal and spatial distribution of the DSL ligands during vascular morphogenesis and further suggest exclusive signaling roles for these ligands in endothelial and mural cells. 
Materials and methods

Retina collection
Eyes were isolated from P3, P5, P7, and P15 C57/Bl6J pups and Wxed in 2% (w/v) paraformaldehyde (PFA) in 1£ phosphate buVered saline (PBS) for 10 min. The cornea, sclera, lens, vitreous, and hyaloid vessels were removed in 1£ PBS and retinas were then dissected. Radial incisions were made at equal intervals along the edge of the retinas. Specimens were Wxed for 2 h in 2% PFA before storage in 1£ PBS. At least three retinas were examined for each antibody at each time point.
Immunohistochemistry on whole-mount retinas
Whole-mount retinas were incubated in 1£ PBS containing 5% donkey serum (Jackson ImmunoReserach) and 0.3% Triton X-100 for 1 h at room temperature. Co-immunolocalization of Notch1, Jagged1, Delta-like1, or Delta-like4 with PECAM was performed by co-incubation of primary and secondary antibodies conjugated with Cy3 and Xuorescein isothiocyanate (FITC). For primary antibodies, cleaved Notch1 (Valine1744, Cell Signaling Technology, MA) was diluted 1:500, anti-Jagged1 (PCR8) (Nehring et al., 2005) was diluted 1:500, anti-Jagged1(C-20, Santa Cruz Biotechnology, Inc., CA) was diluted 1:200, anti-Delta-like1 (148G) (Nehring et al., 2005) was diluted 1:500, anti-Delta-like4 (mDLL4, R&D Systems, MN) was used at 1 g/ml, anti-EphB4 (mEphB4, R&D Systems, MN) was used at 1 g/ml (data not shown), anti-actin, -smooth muscle-FITC (Sigma-Aldrich, MO) was diluted 1:1000, and anti-PECAM-1 was used at 1 g/ml (CD31, BD Pharmingen, CA) in 1£ PBS containing 5% donkey serum and 0.3% Triton X-100 overnight at 4°C. After washing specimens for 1 h with 1£ PBS and 0.05% Tween 20, incubations with secondary antibodies were performed for 3 h at 4°C. For nuclear visualization, TO-PRO-3 (Molecular Probes, OR) was diluted 1:500 (data not shown). After a Wnal wash in 1£ PBS, samples were observed by confocal microscopy on a BioRad MRC1024 using BioRad LaserSharp2000 acquisition software (BioRad, Hercules, CA). For co-localization analysis we examined the samples on a Zeiss LSM 510 Meta NLO two-photon laser scanning confocal microscope. To obtain true co-localization information we also employed the Meta Detector of the Zeiss multiphoton confocal system that can deconvolve the contribution of each Xuorochrome to each pixel by spectral analysis, using information obtained from the reference spectra (FITC and Cy3 alone). The true overlapping pixels were subsequently designated as white (Supplemental Figure) .
